Stock Analysis on Net
Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Common-Size Income Statement

Moderna Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Product sales 100.00 100.00 100.00 0.00 0.00
Cost of sales -29.38 -14.81 -3.97 0.00 0.00
Gross profit 70.62% 85.19% 96.03% — —
Grant revenue 2.10 4.16 264.62 0.00 0.00
Collaboration revenue 2.39 0.35 37.33 0.00 0.00
Research and development -17.87 -11.26 -685.61 0.00 0.00
Selling, general and administrative -6.14 -3.21 -94.19 0.00 0.00
Income (loss) from operations 51.10% 75.22% -381.82% — —
Interest income 1.08 0.10 12.37 0.00 0.00
Gain (loss) on investments -0.11 0.01 0.65 0.00 0.00
Interest expense -0.16 -0.10 -4.95 0.00 0.00
Other income (expense), net 0.02 -0.07 1.25 0.00 0.00
Other income (expense), net -0.24% -0.16% -3.04% — —
Income (loss) before income taxes 51.94% 75.16% -372.49% — —
(Provision for) benefit from income taxes -6.58 -6.13 -1.28 0.00 0.00
Net income (loss) 45.36% 69.04% -373.77% — —
Premium paid on repurchase of preferred stock 0.00 0.00 0.00 0.00 0.00
Cumulative preferred stock dividends 0.00 0.00 0.00 0.00 0.00
Reconciliation of net income (loss) to net income (loss) attributable to common stockholders 0.00% 0.00% 0.00% — —
Net income (loss) attributable to common stockholders 45.36% 69.04% -373.77% — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Income statement item Description The company
Income (loss) from operations The net result for the period of deducting operating expenses from operating revenues. Moderna Inc. income (loss) from operations as a percentage of product sales increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Income (loss) before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Moderna Inc. income (loss) before income taxes as a percentage of product sales increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Moderna Inc. net income (loss) as a percentage of product sales increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.